These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 10969936

  • 1. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease.
    Kawaguchi S, Okuno S, Sakaki T.
    J Neurosurg; 2000 Sep; 93(3):397-401. PubMed ID: 10969936
    [Abstract] [Full Text] [Related]

  • 2. Combined STA-MCA Bypass and Encephalodurosynangiosis Versus Encephalodurosynangiosis Alone in Adult Hemorrhagic Moyamoya Disease: A 5 -Year Outcome Study.
    Zhang M, Raynald, Zhang D, Liu X, Wang R, Zhang Y, Zhao J.
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104811. PubMed ID: 32312630
    [Abstract] [Full Text] [Related]

  • 3. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.
    Kuroda S, Nakayama N, Yamamoto S, Kashiwazaki D, Uchino H, Saito H, Hori E, Akioka N, Kuwayama N, Houkin K.
    J Neurosurg; 2021 Mar 01; 134(3):909-916. PubMed ID: 32168480
    [Abstract] [Full Text] [Related]

  • 4. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
    Wang QN, Bao XY, Zhang Y, Zhang Q, Li DS, Duan L.
    J Neurosurg; 2019 Jun 01; 130(6):1898-1905. PubMed ID: 29999465
    [Abstract] [Full Text] [Related]

  • 5. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P, Steinberg GK.
    J Neurosurg; 2011 Aug 01; 115(2):328-36. PubMed ID: 21529138
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of superficial temporal artery-middle cerebral artery double bypass in patients with hemorrhagic moyamoya disease: surgical effects for operated hemispheric sides.
    Ishiguro T, Okada Y, Ishikawa T, Yamaguchi K, Kawashima A, Kawamata T.
    Neurosurg Rev; 2019 Jun 01; 42(2):559-568. PubMed ID: 30511308
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T.
    Surg Neurol; 2009 Apr 01; 71(4):442-7. PubMed ID: 18514264
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intracranial Hemorrhage After Superficial Temporal Artery-Middle Cerebral Artery Direct Anastomosis for Adults with Moyamoya Disease.
    Park W, Park ES, Lee S, Park JC, Chung J, Lee JM, Ahn JS.
    World Neurosurg; 2018 Nov 01; 119():e774-e782. PubMed ID: 30096496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.